AnaptysBio Inc

Healthcare · Biotechnology

51.00$ -1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 330 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANAB
Line item	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	58	56	62	131	130	122	329	315	306	523	509	494	480	452	435	424	402	385	417	396	427	424	643	625	604	619	610	552	517	487	452	406	427	493	484	422	335	353	364	330
Current Assets	55	52	58	110	116	120	253	252	272	503	434	422	431	425	378	371	385	346	397	387	398	387	554	512	453	450	447	437	439	428	407	372	367	449	432	363	292	331	350	316
Cash	51	47	51	97	31	27	81	69	57	293	114	106	147	183	171	165	221	209	250	284	332	336	496	166	72	59	71	95	35	26	36	54	72	192	123	99	44	110	238	248
Cash & Short-Term Investments	51	47	51	103	106	116	248	248	268	494	427	416	422	421	374	362	378	338	394	380	391	374	548	506	442	443	441	431	429	413	391	355	351	430	385	340	266	249	312	286
Receivables	3.6	4.2	5.3	5.0	5.6	1.5	1.6	1.6	0.2	5.2	0.2	0.2	5.0	–	–	5.0	–	–	–	1.2	0.6	0.8	0.9	0.9	1.0	1.2	1.4	1.5	3.2	3.3	6.9	7.1	9.0	12	41	18	21	76	34	26
Inventory	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	0.1	0.1	0.1	-0.9	–	0.0	–	0.0	0.0	–	0.0	0.0	0.0	0.0	-12	–	–	–	–	–	–
Property, Plant & Equipment	0.5	0.4	0.5	0.6	0.5	0.5	0.7	0.7	1.1	1.3	1.4	3.5	3.2	3.3	3.0	2.8	2.5	1.6	1.8	1.8	23	2.4	2.3	2.2	21	2.0	2.1	2.0	2.0	19	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	14	11	23	21	21	21	22	20	21	23	23	26	32	31	30	24	20	25	20	14	41	41	287	294	300	341	348	361	369	367	364	358	417	409	413	388	380	383	327	317
Current Liabilities	8.8	7.5	5.7	8.1	10	11	14	14	17	21	22	25	31	30	30	23	20	24	20	14	21	21	16	20	20	21	26	36	42	39	37	32	40	44	45	44	36	38	39	42
Short-Term Debt	1.0	1.6	0.0	1.3	3.1	5.0	6.9	7.5	7.5	7.5	7.6	7.3	5.6	3.9	2.2	0.9	0.9	0.9	0.3	0.2	0.6	1.1	1.5	1.5	1.6	1.6	1.6	1.7	1.7	1.7	1.8	1.8	1.9	1.9	1.9	2.0	2.0	2.0	2.1	2.1
Accounts Payable	2.1	1.4	2.3	2.5	3.7	2.6	2.3	2.4	4.4	6.2	5.4	9.1	11	11	16	8.6	6.3	5.5	4.2	2.5	4.1	5.7	1.7	2.5	1.6	3.0	2.8	3.2	4.8	6.5	4.7	4.6	4.9	3.6	4.0	6.1	3.3	2.9	3.9	7.5
Long-Term Debt	4.0	3.4	14	13	11	9.3	7.6	5.8	4.1	2.4	0.6	1.3	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	44	45	39	110	109	101	308	295	285	500	486	468	448	421	405	401	381	360	397	382	386	384	356	331	304	278	262	191	148	120	88	48	9.9	84	71	34	-45	-29	37	13
Retained Earnings	-49	-50	-55	-66	-69	-78	-85	-100	-114	-130	-147	-169	-193	-224	-244	-252	-274	-298	-264	-282	-283	-289	-322	-358	-391	-424	-450	-495	-535	-572	-614	-658	-705	-738	-759	-799	-837	-822	-773	-825
Shares Outstanding	5.1	2.6	2.6	15	20	20	23	24	24	24	27	27	27	27	27	27	27	27	28	27	27	27	28	28	28	28	28	28	27	27	27	27	27	29	30	31	29	29	31	29

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings